Keros Therapeutics, Inc. (KROS)
9.36
-0.09
(-0.95%)
USD |
NASDAQ |
Nov 06, 16:00
9.315
-0.04
(-0.48%)
After-Hours: 20:00
Keros Therapeutics Price : 9.36 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 9.74 | 9.98 | 9.26 | 9.36 | 192039.0 |
| Nov 05, 2026 | 10.84 | 10.98 | 9.37 | 9.45 | 238430.0 |
| Nov 04, 2026 | 11.13 | 11.22 | 10.80 | 10.83 | 128261.0 |
| Nov 03, 2026 | 10.78 | 11.11 | 10.78 | 10.83 | 105963.0 |
| Nov 02, 2026 | 11.12 | 11.39 | 10.52 | 10.76 | 139245.0 |
| Oct 30, 2026 | 11.32 | 11.49 | 10.98 | 11.04 | 120160.0 |
| Oct 29, 2026 | 11.71 | 11.88 | 11.21 | 11.36 | 205119.0 |
| Oct 28, 2026 | 11.34 | 11.79 | 11.20 | 11.61 | 183224.0 |
| Oct 27, 2026 | 11.37 | 11.63 | 11.19 | 11.42 | 148511.0 |
| Oct 26, 2026 | 11.30 | 11.51 | 11.20 | 11.33 | 112410.0 |
| Oct 23, 2026 | 11.28 | 11.34 | 10.92 | 11.28 | 120902.0 |
| Oct 22, 2026 | 11.15 | 11.44 | 11.15 | 11.35 | 115512.0 |
| Oct 21, 2026 | 11.40 | 11.68 | 11.11 | 11.18 | 178141.0 |
| Oct 20, 2026 | 11.04 | 11.66 | 11.04 | 11.40 | 153379.0 |
| Oct 19, 2026 | 10.68 | 11.15 | 10.66 | 11.06 | 210647.0 |
| Oct 16, 2026 | 11.11 | 11.13 | 10.63 | 10.66 | 169639.0 |
| Oct 15, 2026 | 11.13 | 11.40 | 10.98 | 11.10 | 96665.00 |
| Oct 14, 2026 | 11.07 | 11.30 | 10.92 | 11.05 | 159137.0 |
| Oct 13, 2026 | 11.65 | 11.69 | 11.19 | 11.23 | 144293.0 |
| Oct 12, 2026 | 11.77 | 12.08 | 11.58 | 11.61 | 223679.0 |
| Oct 09, 2026 | 11.58 | 12.26 | 11.49 | 11.95 | 194393.0 |
| Oct 08, 2026 | 11.13 | 11.76 | 10.99 | 11.64 | 245658.0 |
| Oct 07, 2026 | 10.81 | 11.34 | 10.81 | 11.21 | 195963.0 |
| Oct 06, 2026 | 11.56 | 11.63 | 10.95 | 11.01 | 185318.0 |
| Oct 05, 2026 | 11.38 | 11.56 | 11.07 | 11.52 | 132408.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agios Pharmaceuticals, Inc. | 29.41 |
| Viking Therapeutics, Inc. | 26.84 |
| Protagonist Therapeutics, Inc. | 132.04 |
| ACADIA Pharmaceuticals, Inc. | 21.23 |
| Alnylam Pharmaceuticals, Inc. | 155.94 |
Price Related Metrics
| PS Ratio | 16.72 |
| Price to Book Value | 0.7075 |
| Earnings Yield | -39.53% |
| Market Cap | 185.58M |